Simulations Plus Inc. logo

SLP

Simulations Plus Inc.

$63.2

Earnings Summary

Revenue
$14.96Mn
Net Profits
$4.09Mn
Net Profit Margins
27.32%

Highlights

Revenue:

Simulations Plus Inc.’s revenue jumped 17.08% since last year same period to $14.96Mn in the Q2 2022. On a quarterly growth basis, Simulations Plus Inc. has generated 1.1% jump in its revenue since last 3-months.

Net Profits:

Simulations Plus Inc.’s net profit jumped 7.92% since last year same period to $4.09Mn in the Q2 2022. On a quarterly growth basis, Simulations Plus Inc. has generated -7.3% fall in its net profits since last 3-months.

Net Profit Margins:

Simulations Plus Inc.’s net profit margin fell -7.82% since last year same period to 27.32% in the Q2 2022. On a quarterly growth basis, Simulations Plus Inc. has generated -8.31% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Simulations Plus Inc. post its latest quarter earnings

EPS Estimate Current Quarter
0.25
EPS Estimate Current Year
0.25

Highlights

EPS Estimate Current Quarter:

Simulations Plus Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.25 - a 38.89% jump from last quarter’s estimates.

EPS Estimate Current Year:

Simulations Plus Inc.’s earning per share (EPS) estimates for the current year stand at 0.25.

Key Ratios

Key ratios of the Simulations Plus Inc. post its Q2 2022 earnings

Earning Per Share (EPS)
0.2

Highlights

Earning Per Share (EPS):

Simulations Plus Inc.’s earning per share (EPS) jumped 11.11% since last year same period to 0.2 in the Q2 2022. This indicates that the Simulations Plus Inc. has generated 11.11% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-04-08
0.14
0.21
50%
2022-07-08
0.18
0.2
11.11%

Company Information

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. The company's technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide.

Organisation
Simulations Plus Inc.
Employees
133
Industry
Technology Services